BIOEX — Bioextrax AB publ Income Statement
0.000.00%
Last trade - 00:00
- SEK103.19m
- SEK89.79m
- SEK2.06m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.022 | 0.276 | 0.395 | 2.06 |
Cost of Revenue | |||||
Gross Profit | — | -0.735 | -0.757 | -0.95 | 0.718 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.99 | 5.59 | 10.8 | 19.1 | 23.7 |
Operating Profit | -1.99 | -5.57 | -10.5 | -18.7 | -21.6 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.99 | -5.57 | -10.5 | -18.7 | -21.5 |
Net Income After Taxes | -1.99 | -5.57 | -10.5 | -18.7 | -21.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.99 | -5.57 | -10.5 | -18.7 | -21.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.99 | -5.57 | -10.5 | -18.7 | -21.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.189 | -0.419 | -0.684 | -1.1 | -0.804 |
Dividends per Share |